← Back to Search

Behavioral Intervention

Support Group Program for Progressive Aphasia

Phase < 1
Recruiting
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately following treatment, follow-up at 2-months post-treatment
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to study the benefits of a support group program for people with progressive aphasia and their caregivers. They will use assessments before, after treatment, and follow-up to measure the effects of the

Who is the study for?
This trial is for bilingual and Spanish-speaking individuals with progressive aphasia or related conditions, such as Frontotemporal Dementia, and their carepartners. Participants can join from the U.S., Mexico, Spain, and may participate through tele-based means if preferred.
What is being tested?
The study tests an educational support group program that includes psychoeducational support and communication skills training. It measures changes in psychosocial function, communicative effectiveness, and speech/language function before, after treatment, and at follow-up.
What are the potential side effects?
Since this intervention is non-medical focusing on education and support groups rather than drugs or medical procedures, traditional side effects are not expected; however participants might experience emotional discomfort or fatigue during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately following treatment, follow-up at 2-months post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately following treatment, follow-up at 2-months post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Treatment/Acceptability Survey
Secondary study objectives
% completion of homework
% participants who complete intervention, % sessions completed
Acceptability Measure
+25 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment ConditionExperimental Treatment1 Intervention
Support group meetings and strategy practice

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
378 Previous Clinical Trials
86,485 Total Patients Enrolled
~80 spots leftby May 2030